The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
Abstract
Object. Data obtained preoperatively from three-dimensional (3D)/proton magnetic resonance (MR) spectroscopy were compared with the results of histopathological assays of tissue biopsies obtained during surgery to verify the sensitivity and specificity of a choline-containing compound—N-acetylaspartate index (CNI) used to distinguish tumor from nontumorous tissue within T 2 hyperintense and contrast-enhancing lesions of patients with untreated gliomas. The information gleaned from the biopsy correlation study was used to test the hypothesis that there is metabolically active tumor in nonenhancing regions of the T 2-hyperintense lesion that can be detected using MR spectroscopy. Methods. Patients suspected of harboring a glioma underwent 3D MR spectroscopy during their preoperative MR imaging examination. Surgical navigation techniques were used to record the location of tissue biopsies collected during open resection of the tumor. A receiver operating curve analysis of the CNI and histological characteristics of specimens at each biopsy location was performed to determine the optimal threshold of the CNI required to separate tumor from nontumorous tissue. Histograms of the CNIs within enhancing and nonenhancing regions of lesions appearing on MR images were generated to determine the spatial distribution of CNIs consistent with tumor. Conclusions. Biopsy samples containing tumor were distinguished from those containing a mixture of normal, edematous, gliotic, and necrotic tissue with 90% sensitivity and 86% specificity by using a CNI threshold of 2.5. The CNIs of nontumorous specimens were significantly different from those of biopsy specimens containing Grade II (p < 0.03), Grade III (p < 0.005), and Grade IV (p < 0.01) tumors. On average, one third to one half of the T 2-hyperintense lesion outside the contrast-enhancing lesion contained CNI greater than 2.5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
Preul, M. C., Caramanos, Z., Collins, D. L., Villemure, J.-G., Leblanc, R., Olivier, A., Pokrupa, R., & Arnold, D. L. (1996) · Nature Medicine · doi:10.1038/nm0396-323 · Cited by 523
Dowling, C., Bollen, A. W., Noworolski, S. M., McDermott, M. W., Barbaro, N. M., Day, M. R., Henry, R. G., Chang, S. M., Dillon, W. P., Nelson, S. J., et al. (2001) · PubMed Central · Cited by 378
Self-citationGupta, R. K., Cloughesy, T. F., Sinha, U., Garakian, J., Lazareff, J., Rubino, G., Rubino, L., Becker, D. P., Vinters, H. V., & Alger, J. R. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006431120031 · Cited by 278
Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer
Tran, T.-K. C., Vigneron, D. B., Sailasuta, N., Tropp, J., Le Roux, P., Kurhanewicz, J., Nelson, S., & Hurd, R. (2000) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(200001)43:1<23::aid-mrm4>3.0.co;2-e · Cited by 238
Self-citationCroteau, D., Scarpace, L., Hearshen, D., Gutierrez, J., Fisher, J. L., Rock, J. P., & Mikkelsen, T. (2001) · Neurosurgery · doi:10.1097/00006123-200110000-00008 · Cited by 178
Cited by
Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox175 · Cited by 746
Diffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
Soares, D. P., & Law, M. (2009) · Clinical Radiology · doi:10.1016/j.crad.2008.07.002 · Cited by 459
Current Clinical Brain Tumor Imaging
Villanueva-Meyer, J. E., Mabray, M. C., & Cha, S. (2017) · Neurosurgery · doi:10.1093/neuros/nyx103 · Cited by 453
Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging
Horská, A., & Barker, P. B. (2010) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2010.04.003 · Cited by 356
Metadata
- Authors
- McKnight, T. R., von dem Bussche, M. H., Vigneron, D. B., Lu, Y., Berger, M. S., McDermott, M. W., Dillon, W. P., Graves, E. E., Pirzkall, A., & Nelson, S. J.
- Venue
- Journal of Neurosurgery
- Published
- 2002-10
- Volume
- 97
- Issue
- 4
- Pages
- 794-802
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W1990556342
- Cited by
- 272
- References
- 16
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. https://app.cochat.ai/papers/10.3171/jns.2002.97.4.0794
- The paper
- McKnight, T. R., von dem Bussche, M. H., Vigneron, D. B., Lu, Y., Berger, M. S., McDermott, M. W., Dillon, W. P., Graves, E. E., Pirzkall, A., & Nelson, S. J. (2002). Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. Journal of Neurosurgery. https://doi.org/10.3171/jns.2002.97.4.0794
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.